Literature DB >> 8811993

Clinical and neuropathological findings in Lewy body dementias.

D Galasko1, R Katzman, D P Salmon, L Hansen.   

Abstract

We compared clinical features in three groups of pathologically defined patients evaluated for dementia during life: (i) Alzheimer's disease (AD); (ii) Lewy body variant of Alzheimer's Disease (LBV), with Lewy bodies (LB) and AD; (iii) diffuse Lewy body disease (DLBD), with LB alone. All three groups had similar initial cognitive symptoms. LBV and DLBD had Parkinsonian signs, though resting tremor was extremely rare. Delusions and hallucinations were relatively more frequent in LBV and DLBD than in AD. On neuropsychological testing, the LBV group had relatively greater impairment than AD on visuospatial and executive tests. LB therefore contribute to the clinical picture of dementia.

Entities:  

Mesh:

Year:  1996        PMID: 8811993     DOI: 10.1006/brcg.1996.0040

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  43 in total

1.  Pentagon copying is more impaired in dementia with Lewy bodies than in Alzheimer's disease.

Authors:  T A Ala; L F Hughes; G A Kyrouac; M W Ghobrial; R J Elble
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-04       Impact factor: 10.154

Review 2.  Lewy bodies and dementia.

Authors:  D Galasko
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

3.  Visual search in Dementia with Lewy Bodies and Alzheimer's disease.

Authors:  Kelly M Landy; David P Salmon; J Vincent Filoteo; William C Heindel; Douglas Galasko; Joanne M Hamilton
Journal:  Cortex       Date:  2015-09-21       Impact factor: 4.027

4.  Cognitive tests aid in clinical differentiation of Alzheimer's disease versus Alzheimer's disease with Lewy body disease: Evidence from a pathological study.

Authors:  Martina Azar; Silvia Chapman; Yian Gu; James B Leverenz; Yaakov Stern; Stephanie Cosentino
Journal:  Alzheimers Dement       Date:  2020-06-19       Impact factor: 21.566

5.  Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.

Authors:  D W Tsuang; R K Wilson; O L Lopez; E K Luedecking-Zimmer; J B Leverenz; S T DeKosky; M I Kamboh; R L Hamilton
Journal:  Neurology       Date:  2005-02-08       Impact factor: 9.910

Review 6.  Cognitive impairment and dementia in patients with Parkinson disease.

Authors:  James B Leverenz; Joseph F Quinn; Cyrus Zabetian; Jing Zhang; Kathleen S Montine; Thomas J Montine
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

7.  The new Qualitative Scoring MMSE Pentagon Test (QSPT) as a valid screening tool between autopsy-confirmed dementia with Lewy bodies and Alzheimer's disease.

Authors:  Micaela Mitolo; David P Salmon; Simona Gardini; Douglas Galasko; Enzo Grossi; Paolo Caffarra
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  Posterior cortical atrophy: a brief review.

Authors:  Howard S Kirshner; Patrick J M Lavin
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

9.  Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies.

Authors:  Joanne M Hamilton; David P Salmon; Douglas Galasko; Rema Raman; Jenn Emond; Lawrence A Hansen; Eliezer Masliah; Leon J Thal
Journal:  Neuropsychology       Date:  2008-11       Impact factor: 3.295

10.  Alterations in mGluR5 expression and signaling in Lewy body disease and in transgenic models of alpha-synucleinopathy--implications for excitotoxicity.

Authors:  Diana L Price; Edward Rockenstein; Kiren Ubhi; Van Phung; Natalie MacLean-Lewis; David Askay; Anna Cartier; Brian Spencer; Christina Patrick; Paula Desplats; Mark H Ellisman; Eliezer Masliah
Journal:  PLoS One       Date:  2010-11-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.